The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00227201
First received: September 23, 2005
Last updated: April 23, 2008
Last verified: April 2008
  Purpose

The objective of this study is to better understand strategies used by African Americans with hypertension in order to control their blood pressure.


Condition Intervention
Hypertension
Behavioral: Self-affirmation intervention

Study Type: Observational
Official Title: The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans

Resource links provided by NLM:


Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:
  • The impact of positive affect induction and self-affirmation on medication adherence and blood pressure control.

Estimated Enrollment: 60
Study Start Date: June 2003
Estimated Study Completion Date: May 2005
Detailed Description:

The objective of this study is to better understand strategies used by African Americans with hypertension in order to control their blood pressure. Through the use of qualitative interviews, the beliefs and attitudes toward complementary medicine of African Americans with hypertension will be elucidated.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Patients will be African-American adults 18 years or older who were diagnosed with poorly controlled hypertension as defined by the 6th Joint National Committee guidelines (systolic >140 and diastolic >90).
  2. Patients will also be eligible if they are taking any prescribed anti-hypertensive medications.
  3. Patients must be able to provide informed consent in English. Participants will be recruited from Cornell Internal Medicine Associates, the primary care and general medicine practice at Cornell Medical Center, the same site as the parent grant.

Exclusion Criteria:

  1. Patients who refused to participate.
  2. Patients who are unable to provide informed consent.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00227201

Locations
United States, New York
New York Presbyterian Hospital-Weill Medical College
New York, New York, United States, 10021
Sponsors and Collaborators
Weill Medical College of Cornell University
Investigators
Principal Investigator: Jason Moore Weill Medical College of Cornell University
Principal Investigator: Mary E Charlson, MD Weill Medical College of Cornell University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00227201     History of Changes
Other Study ID Numbers: 0301005948
Study First Received: September 23, 2005
Last Updated: April 23, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by Weill Medical College of Cornell University:
African-American
Hypertension
Complementary medicine
Medication adherence

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 18, 2014